ARCT EPS Estimates
Arcturus Therapeutics Holdings Inc.
$11.36
+$0.24(+2.16%)
43
Overall
60
Value
40
Tech
31
Quality
Market Cap
$316.06M
Volume
364.71K
52W Range
$5.50 - $24.17
Target Price
$22.00
ARCT EPS estimates: the consensus estimate for Arcturus Therapeutics Holdings Inc.'s current fiscal year is -$3.48 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ARCT EPS Estimates
- EPS estimate, current quarter
- $-0.60
- EPS estimate, next quarter
- $-1.01
- EPS estimate, current year
- $-3.48
- EPS estimate, next year
- $-3.59
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.40 |
| 2024 | $-3.00 |
| 2023 | $-1.12 |
| 2022 | $0.35 |
| 2021 | $-7.74 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARCT | $11.36 | +2.2% | 364.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arcturus Therapeutics Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW